---
title: "12:25 ETShareholder Alert: Ademi LLP investigates whether Cloopen Group Holding Limited is obtaining a Fair Price for Public Shareholders"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286132236.md"
description: "Ademi LLP is investigating Cloopen Group Holding Limited (OTC: RAASY) for potential breaches of fiduciary duty related to its recent transaction with a consortium led by CEO Changxun Sun. The investigation focuses on whether the Cloopen board is acting in the best interests of shareholders, as the deal includes significant penalties for accepting competing bids. Shareholders are set to receive $0.4940 per ordinary share and $2.9641 per American Depositary Share in a transaction valued at approximately $162.89 million."
datetime: "2026-05-12T16:25:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286132236.md)
  - [en](https://longbridge.com/en/news/286132236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286132236.md)
---

# 12:25 ETShareholder Alert: Ademi LLP investigates whether Cloopen Group Holding Limited is obtaining a Fair Price for Public Shareholders

MILWAUKEE, May 12, 2026 /PRNewswire/ -- Ademi LLP is investigating Cloopen (OTC: RAASY) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with a consortium led by founder and CEO Changxun Sun.

Click here to learn how to join our investigation and obtain additional information or contact us at \[email protected\] or toll-free: 866-264-3995. There is no cost or obligation to you.

Cloopen stockholders will receive $0.4940 per ordinary share and $2.9641 per American Depositary Share in a going-private transaction valued at approximately $162.89 million. Cloopen insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Cloopen by imposing a significant penalty if Cloopen accepts a competing bid. We are investigating the conduct of the Cloopen board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP  
Guri Ademi  
Toll Free: (866) 264-3995  
Fax: (414) 482-8001

SOURCE Ademi LLP

### Related Stocks

- [RAASY.US](https://longbridge.com/en/quote/RAASY.US.md)

## Related News & Research

- [Cloopen Enters into Definitive Merger Agreement for Going-Private Transaction | RAASY Stock News](https://longbridge.com/en/news/286084516.md)
- [Hi Sun updates market on Cloopen privatization deal and potential value uplift](https://longbridge.com/en/news/286125526.md)
- [Could Buying Bitcoin Today Still Set You Up for Life?](https://longbridge.com/en/news/286935802.md)
- [Undervalued Penny Stocks Worth Watching In May 2026](https://longbridge.com/en/news/286139974.md)
- [Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT](https://longbridge.com/en/news/286953224.md)